Halozyme Therapeutics | HALO - Stock

Stock Price
81.23
Daily Change
2.81 3.58%
Monthly
8.15%
Yearly
42.26%
Q1 Forecast
69.50

Halozyme Therapeutics reported $185.8M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
Agios Pharmaceuticals USD 32.03M 1.19M Sep/2025
Alnylam Pharmaceuticals USD 75.38M 3.7M Sep/2025
Amarin USD 184.7M 13.46M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Baxter International USD 2.46B 76M Sep/2025
Cytokinetics USD 0 0 Dec/2023
Eli Lilly USD 12.18B 1.17B Sep/2025
Halozyme Therapeutics USD 185.8M 4.29M Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
MannKind USD 26.97M 1.52M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
United Therapeutics USD 176.5M 7.3M Sep/2025